Guangzhou Hanfang Leading Chinese Producer of LiposomeGrade Egg Yolk Lecithin

Domestic Manufacturer Breaks Global Monopoly with FDA, CEP-Certified Injectable Grade Ingredients

【Guangzhou, China】–【2026】– Guangzhou Hanfang Pharmaceutical Company Limited, a leading provider of high-end pharmaceutical lipid excipients and health products, today highlights its position as a top Chinese producer of egg yolk lecithin for liposome formulations. This domestically developed injectable-grade ingredient addresses critical supply chain gaps for global pharmaceutical and research institutions, featuring green extraction technology, 90% domestic market coverage, and compliance with international quality standards. The product is now available globally through direct sales, distribution partnerships, and custom manufacturing services.

Core Technical Breakthroughs & Product Advantages

First, the product solves long-standing supply chain vulnerabilities for liposome manufacturers. Prior to Hanfang’s breakthrough, global access to injectable-grade egg yolk lecithin was dominated by international suppliers, with domestic Chinese production accounting for only 10% of the market. Hanfang’s solution has raised this figure to 90%, providing a stable, reliable alternative for pharmaceutical companies and research centers.

Second, it adopts an integrated green extraction process combining supercritical CO₂ extraction, membrane separation, and chromatographic separation, replacing traditional high-pollution manufacturing methods. This technology ensures product purity while reducing environmental impact, aligning with global sustainability standards.

Third, the egg yolk lecithin serves as a high-performance emulsifier, solubilizer, and liposome membrane material, meeting strict requirements for injectable emulsions and liposome drug formulations. It is specifically designed to support the development of advanced drug delivery systems.

Global Compliance & Certifications

To meet global market access requirements, Hanfang’s liposome-grade egg yolk lecithin holds key international certifications including US FDA US-DMF, EU CEP, Mexico Cofepris, and India DCGI. These credentials ensure the product complies with regulatory standards in North America, Europe, Asia, and other major global markets.

Supply & Customization Services

The product is available worldwide through Hanfang’s multi-channel distribution model, including direct sales, authorized distributors, and custom manufacturing services. The company serves over 1,000 global clients, with operations spanning more than 20 countries and regions. Customization options are offered to meet specific formulation requirements for pharmaceutical and research partners.

Executive Quote

"Our liposome-grade egg yolk lecithin represents a key milestone in China’s pharmaceutical industry’s drive for technological self-reliance," said Xu Wendong, General Manager and Deputy Director of the National Engineering Research Center at Guangzhou Hanfang Pharmaceutical Company Limited. "By breaking long-standing international monopolies, we provide global partners with a reliable, cost-effective alternative without compromising on quality or regulatory compliance."

Company Profile

Guangzhou Hanfang Pharmaceutical Company Limited was founded in 1998 and is a wholly-owned subsidiary of the Fortune Global 500 Guangzhou Pharmaceutical Holdings. As a national-level specialized, sophisticated, unique, and new "Little Giant" enterprise, it operates the only national engineering research center for pharmaceutical lipids in China, alongside provincial-level research platforms. The company specializes in high-end pharmaceutical lipid excipients, specialty anti-tumor APIs, and Ganoderma health products, with over 240 patents and a global customer base of 1,000+ clients.

Contact Information

Company: Guangzhou Hanfang Pharmaceutical Company Limited
Official Website: http://byshanhanfang.com/

© 2026 Guangzhou Hanfang Pharmaceutical Company Limited. All rights reserved.